We’ll see soon that digital health is simply health care, said Daniel Zlott, PharmD, APhA’s senior vice president of education and business development, during APhA’s second annual DigitalHealth.Rx summit, which was held in-person on March 17, in conjunction with APhA2022 in San Antonio, TX.

According to outpatient clinical trial results recently published in Gut, the common heartburn medication Pepcid (famotidine) could improve the recovery of symptomatic patients diagnosed with COVID-19.

An estimated one in three Americans struggles to afford their medical bills. Who do they go to for help finding solutions to this common problem? “My physician” is the typical answer. But according to a recent study published in JAMA, few are equipped to help.

The health care disruptions created by the public health emergency have revived interest in identifying opportunities to optimize pharmacists’ roles.

In December 2021, FDA permanently lifted a major restriction on medication abortions that had been temporarily lifted earlier in the COVID-19 pandemic. Prior to the pandemic, patients were required to pick up mifepristone in person from a certified prescriber. In 2020, FDA temporarily lifted this in-person requirement. The new change from FDA will permanently allow any certified mail-order or brick-and-mortar pharmacy to dispense the drug with a prescription.